<DOC>
	<DOCNO>NCT00116649</DOCNO>
	<brief_summary>Actinic keratosis ( AK ) skin condition show skin routinely expose sun , face , scalp , shoulder , chest , back , arm , hand . The purpose study evaluate safety one , two , three cycle imiquimod treatment AK . The AK lesion treat adjacent nonadjacent area head , torso , extremity . The total surface area AK lesion must great 25 cm2 . The secondary objective evaluate effectiveness treatment imiquimod people large surface area AK .</brief_summary>
	<brief_title>Open-Label Safety Study Evaluate Imiquimod Cream , 5 % Large Areas Actinic Keratosis</brief_title>
	<detailed_description>This Phase 4 , open-label , single-arm , multicenter study male female subject age 18 year old clinically diagnose AK lesion , conduct 31 investigational site United States . This study assess safety imiquimod treatment AK apply dos range one packet 12.5 mg ) 6 packet ( 75 mg ) either single multiple body region 3 cycle , depend upon treatment success AK lesion recurrence . Eligible subject apply imiquimod 5 % cream prior normal sleeping hour 2 day per week least 4 clinically typical , visible , discrete , nonhypertrophic AK lesion contiguous noncontiguous treatment area total great 25 cm2 baseline . Multiple treatment area could expose ( i.e. , head , torso and/or extremity ) , number packet determine investigator exceed one packet 25 cm2 treatment area , maximum 6 packet per dose . In treatment cycle , dose continue 16 week ( approximately 4 month ) , instructed investigator , follow 2-month , treatment-free follow-up period .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Are least 18 year age . Have great 25 cm2 total treatment area ( ) contain least 4 actinic keratosis lesion . Have skin condition treatment area may make bad treatment imiquimod ( e.g. , rosacea , psoriasis , atopic dermatitis , eczema ) . Have receive specific treatments/medications treatment area ( ) within designated time period prior study treatment initiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>actinic keratosis lesion large head torso extremity</keyword>
	<keyword>actinic keratosis</keyword>
</DOC>